Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI
This study is currently recruiting participants.
Verified April 2013 by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Sponsor:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Collaborator:
University Medical Center Goettingen
Information provided by (Responsible Party):
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
ClinicalTrials.gov Identifier:
NCT01488955
First received: December 7, 2011
Last updated: April 24, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this study, patients with uncomplicated urinary infection are investigated. It is investigated if treatment of only symptoms of the uncomplicated urinary infection is as effective as treatment with antibiotics with respect to the outcome of the urinary infection. If this is the case, the use of antibiotics in the treatment of uncomplicated urinary infections might be reduced.
Secondary aim of the study is the safety evaluation of both treatment strategies with respect to SAEs during treatment. Additionally, relapse frequency after 28 days is evaluated.
| Condition | Intervention | Phase |
|---|---|---|
|
Urinary Tract Infection |
Drug: Ibuprofen Drug: Fosfomycin-Trometamol |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - a Comparative Effectiveness Study in General Practice (ICUTI) |
Resource links provided by NLM:
Drug Information available for:
Tromethamine
Ibuprofen
Ibuprofen sodium
Ibuprofen lysinate
Fosfomycin tromethamine
U.S. FDA Resources
Further study details as provided by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH:
Primary Outcome Measures:
- number of additional treatments with antibiotics combined with number of symptoms [ Time Frame: day 0-28 ] [ Designated as safety issue: Yes ]The study outcome is considered as positive, if the interventional group where only symptoms were treated has less additional treatments with antibiotics as the interventional group, where antibiotics are given from day 0 on. Additionally, the interventional group where only symptoms were treated has to be non inferior with respect to number of symptoms.
Secondary Outcome Measures:
- number of defined daily doses of antibiotics [ Time Frame: day 0-28 ] [ Designated as safety issue: No ]
- number of SAEs [ Time Frame: day 0-28 ] [ Designated as safety issue: Yes ]
- number of relapses [ Time Frame: day 0-28 ] [ Designated as safety issue: No ]
- number of patients without symptoms [ Time Frame: day 4 and day 7 ] [ Designated as safety issue: No ]
- symptom load (AUC) [ Time Frame: day 0-4 ] [ Designated as safety issue: No ]
- symptom load [ Time Frame: day 0-7 ] [ Designated as safety issue: No ]
- symptoms load with regard to specific symptoms [ Time Frame: day 0-7 ] [ Designated as safety issue: No ]
- activity impairment assessment [ Time Frame: day 0-7 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 494 |
| Study Start Date: | February 2012 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Ibuprofen
Ibuprofen 400 mg oral once daily from day 0 for 3 days, placebo granulate oral day 0
|
Drug: Ibuprofen
400 mg oral once a day from day 0 for 3 days
|
|
Experimental: Fosfomycin-Trometamol
Fosfomycin-Trometamol (Monuril) 3 g granulate oral at day 0, placebo to Ibuprofen once a day from day 0 for 3 days
|
Drug: Fosfomycin-Trometamol
8 g granulate with 3 g Fosfomycin-Trometamol oral once at day 0, placebo to Ibuprofen once a day oral from day 0 for 3 days
Other Name: Monuril
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Women (18 - 65 years)
- Symptoms of uncomplicated urinary tract infection: dysuria, frequency/urgency of micturition, and/or low abdominal pain
- written informed consent
Exclusion Criteria:
- fever (> 38,0)
- pain on renal bed percussion
- signs of complicated urinary tract infection
- urinary tract infection within the last two weeks
- antibiotic intake within the last 7 days
- repeated intake of pain medication (i.e. ibuprofen, diclofenac) within the last 24 hours, or continuous pain medication
- known pregnancy/lactation period
- current immunosuppressive therapy
- known renal insufficiency
- known renal abnormalities
- current urine catheterization
- serious neurological diseases
- limited condition due to other disorders
- contraindications towards trial medication
- current/anamnestic gastrointestinal haemorrhagia
- known allergy towards trial medication
- current intake of drugs potentially interacting with trial medication (i.e. oral corticosteroids, anticoagulates)
- poor communication/cooperation skills
- disability to understand trial information, poor German language skills
- current participation in another clinical trial or clinical trial participation within the last 4 weeks
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01488955
Contacts
| Contact: Jutta Bleidorn, MD | +49 511 532 ext 2744 | Bleidorn.Jutta@mh-hannover.de |
| Contact: Ildiko Gagyor, MD | +49 551 3914221 | igagyor@gwdg.de |
Locations
| Germany | |
| Medical Practice Hermann | Recruiting |
| Adelebsen, Germany, 37139 | |
| Contact: Cornelia Hermann, MD +49-5506-95750 Dr.C.Hermann@googlemail.com | |
| Principal Investigator: Cornelia Hermann, MD | |
| Sub-Investigator: Marten Hiller | |
| Medical Practice Seker | Recruiting |
| Bad Gandersheim, Germany, 37581 | |
| Contact: Güsün Seker +49-5382-2684 | |
| Principal Investigator: Güsün Seker | |
| Medical Practice Zimny | Not yet recruiting |
| Bad Pyrmont, Germany, 31812 | |
| Contact: Hans-Hermann Zimny, Dr. med. +49-5281-606248 dr.zimny@t-online.de | |
| Principal Investigator: Hans-Hermann Zimny, Dr. med. | |
| Medical Practice Coutelle | Recruiting |
| Bremen, Germany, 28197 | |
| Contact: Alexander Coutelle, MD +49-421-540852 praxis@familienmedizin-bremen.de | |
| Principal Investigator: Alexander Coutelle, MD | |
| Medical Practice Zedler | Recruiting |
| Bremen, Germany, 28777 | |
| Contact: Siegmar Zedler, MD +49-421-68667 dr.zedler@t-online.de | |
| Principal Investigator: Siegmar Zedler, MD | |
| Medical Practice Schelp | Recruiting |
| Bremen, Germany, 28259 | |
| Contact: Holger Schelp +49-421-5797675 Holger-Schelp@gmx.de | |
| Principal Investigator: Holger Schelp | |
| Sub-Investigator: Martin Gerken, MD | |
| Medical Practice Dickow | Not yet recruiting |
| Burgwedel, Germany, 30938 | |
| Contact: Mona Dickow, Dr. med. +49-5139-891929 | |
| Principal Investigator: Mona Dickow, Dr. med. | |
| Medical Practice Brucker I | Recruiting |
| Destedt, Germany, 38162 | |
| Contact: Klaus Peter Brucker, MD +49-5306-1303 dr.brucker@t-online.de | |
| Principal Investigator: Klaus Peter Brucker, MD | |
| Medical Practice Rötterink | Not yet recruiting |
| Garbsen, Germany, 30823 | |
| Contact: Hans-Hendrik Rötterink, Dr. med. +49-5137-77788 hendrik.roetterink@web.de | |
| Principal Investigator: Hans-Hendrik Rötterink, Dr. med. | |
| Medical Practice Müller | Not yet recruiting |
| Gillersheim, Germany, 37191 | |
| Contact: Manfred Müller, Dr. med. +49-5556-1088 Praxis.Manfred.Mueller@t-online.de | |
| Principal Investigator: Manfred Müller, Dr. med. | |
| Dept. of General Medicine, Univercity Medical Center Goettingen | Not yet recruiting |
| Goettingen, Germany, 37073 | |
| Contact: Ildiko Gagyor, MD +49-551-3914226 | |
| Principal Investigator: Ildiko Gagyor, MD | |
| Medical Practice Keske | Recruiting |
| Göttingen, Germany, 37081 | |
| Contact: Wolfgang Keske, MD +49-551-91191 wkeske@dgn.de | |
| Principal Investigator: Wolfgang Keske, MD | |
| Medical Practice Lückerath | Recruiting |
| Göttingen, Germany, 37077 | |
| Contact: Marianne Lückerath, MD +49-551-24510 mlueckerath@gmx.de | |
| Principal Investigator: Marianne Lückerath, MD | |
| Sub-Investigator: Maria Saborowski, MD | |
| Medical Practice Koch | Recruiting |
| Göttingen, Germany, 37081 | |
| Contact: Thomas Koch, MD +49-551-61700 koch.leuckel@t-online.de | |
| Principal Investigator: Thomas Koch, MD | |
| Medical Practice Borchers | Recruiting |
| Hannover, Germany, 30539 | |
| Contact: Christoph Borchers, MD +49-511-520237 info@hausarztpraxis-bemerode.de | |
| Principal Investigator: Christoph Borchers, MD | |
| Dept. of General Medicine, MHH Hannover | Not yet recruiting |
| Hannover, Germany, 30625 | |
| Contact: Jutta Bleidorn, MD | |
| Principal Investigator: Jutta Bleidorn, MD | |
| Medical Practice Kuhlmann | Recruiting |
| Hannover, Germany, 30159 | |
| Contact: Birger Kuhlmann, MD +49-511-2206440 | |
| Principal Investigator: Birger Kuhlmann, MD | |
| Sub-Investigator: Hans Heiken, MD | |
| Sub-Investigator: Stefanie Holm, MD | |
| Medical Practice Baumgarten | Recruiting |
| Hannover, Germany, 30419 | |
| Contact: Hans-Bernd Baumgarten, MD +49-551-792665 hbbaumgarten@hausarzt.de | |
| Principal Investigator: Hans-Bernd Baumgarten, MD | |
| Medical Practice Kiwit-Putzer | Recruiting |
| Hannover, Germany, 30938 | |
| Contact: Dorothee Kiwit-Putzer, MD +49-5139-8112 | |
| Principal Investigator: Dorothee Kiwit-Putzer, MD | |
| Medical Practice Glatzel | Recruiting |
| Hannover, Germany, 30163 | |
| Contact: Dirk Glatzel, MD +49-511-638282 Glatzel@arcor.de | |
| Principal Investigator: Dirk Glatzel, MD | |
| Medical Practice Dockhorn | Recruiting |
| Hannover, Germany, 30179 | |
| Contact: Uwe Dockhorn, MD +49-511-6045979 | |
| Principal Investigator: Uwe Dockhorn, MD | |
| Medical Practice Gosewisch | Recruiting |
| Hannover, Germany, 30659 | |
| Contact: Andrea Gosewisch, MD +49-511-6461916 praxis@dr-gosewisch-bothfeld.de | |
| Principal Investigator: Andrea Gosewisch, MD | |
| Medical Practice Buck | Recruiting |
| Hannover, Germany, 30161 | |
| Contact: Andreas Buck, MD +49-511-312828 DrAndreasBuck@aol.com | |
| Principal Investigator: Andreas Buck, MD | |
| Medical Practice Klinger-Bültemann | Recruiting |
| Hannover, Germany, 30655 | |
| Contact: Sabine Klinger-Bültemann, MD +49-511-5477788 klinger-bueltemann@htp-tel.de | |
| Principal Investigator: Sabine Klinger-Bültemann, MD | |
| Medical Practice Hart | Not yet recruiting |
| Hannover, Germany, 30655 | |
| Contact: Birgit Hart +49-511-5476390 birgit.hart@arcor.de | |
| Principal Investigator: Birgit Hart | |
| Medical Practice Menke | Recruiting |
| Hannover, Germany, 30171 | |
| Contact: Holger Menke, MD +49-511-851916 drhmenke@t-online.de | |
| Principal Investigator: Holger Menke, MD | |
| Medical Practice Löber | Recruiting |
| Hardegsen, Germany, 37181 | |
| Contact: Matthias Löber, MD +49-5505-5122 matthiasloeber@aol.com | |
| Principal Investigator: Matthias Löber, MD | |
| Sub-Investigator: Per-Christian Knöpfel | |
| Medical Practice Wilde | Recruiting |
| Hildesheim, Germany, 31134 | |
| Contact: Elmar Wilde, MD +49-5121-57774 | |
| Principal Investigator: Elmar Wilde, MD | |
| Medical Practice Beverungen | Recruiting |
| Höxter-Lüchtringen, Germany, 37671 | |
| Contact: Regina Beverungen, MD +49-5271-97400 dr.beverungen@telemed.de | |
| Principal Investigator: Regina Beverungen, MD | |
| Medical Practice Meggers | Recruiting |
| Langenhagen, Germany, 30855 | |
| Contact: Jörg Meggers +49-511-743086 | |
| Principal Investigator: Jörg Meggers | |
| Medical Practice Ertel | Recruiting |
| Langwedel-Daverden, Germany, 27299 | |
| Contact: Matthias Ertel, MD +49-4232-93260 mertel1001@aol.com | |
| Principal Investigator: Matthias Ertel, MD | |
| Medical Practice Schmitz | Not yet recruiting |
| Neustadt am Rübenberge, Germany, 31535 | |
| Contact: Henrik Schmitz, Dr. med. +49-5034-777 henrik.schmitz@t-online.de | |
| Principal Investigator: Henrik Schmitz, Dr. med. | |
| Medical Practice Falkenstein | Recruiting |
| Oldenburg, Germany, 26127 | |
| Contact: Marc Falkenstein, MD +49-441-302250 Hausarzt-Falkenstein@t-online.de | |
| Principal Investigator: Marc Falkenstein, MD | |
| Medical Practice Gemen | Recruiting |
| Pattensen, Germany, 30982 | |
| Contact: Marion Gemen, MD +49-5101-915459 gemen@arztpraxis-pattensen.de | |
| Principal Investigator: Marion Gemen, MD | |
| Medical Practice Preiskorn | Not yet recruiting |
| Rehburg-Loccum, Germany, 31547 | |
| Contact: Axel Preiskorn, Dr. med. +49-5766-96060 axel.preiskorn@t-online.de | |
| Principal Investigator: Axel Preiskorn, Dr. med. | |
| Sub-Investigator: Pamela Hilgenberg, Dr. med. | |
| Medical Practice Brockstedt | Recruiting |
| Rosdorf, Germany, 37124 | |
| Contact: Kerstin Brockstedt, MD +49-5509-2160 | |
| Principal Investigator: Kerstin Brockstedt, MD | |
| Medical Practice Meier-Ahrens | Recruiting |
| Rosdorf, Germany, 37124 | |
| Contact: Karin Meier-Ahrens, MD +49-551-78452 karin.meier-ahrens@gmx.net | |
| Principal Investigator: Karin Meier-Ahrens, MD | |
| Sub-Investigator: Ildiko Gagyor, MD | |
| Medical Practice Böttcher | Not yet recruiting |
| Schwanewede, Germany, 28790 | |
| Contact: Susanne Böttcher +49-4209-930499 luetjen-boettcher@t-online.de | |
| Principal Investigator: Susanne Böttcher | |
| Medical Practice Fleige | Recruiting |
| Sehnde, Germany, 31319 | |
| Contact: Thomas Fleige, MD +49-5138-1084 thomasfleige@aol.com | |
| Principal Investigator: Thomas Fleige, MD | |
| Medical Practice Albrecht | Recruiting |
| Springe, Germany, 31832 | |
| Contact: Frank Albrecht, MD +49-5041972993 info@dr-albrecht-springe.de | |
| Principal Investigator: Frank Albrecht, MD | |
| Medical Practice Schmiemann | Recruiting |
| Verden, Germany, 22283 | |
| Contact: Guido Schmiemann, MD | |
| Principal Investigator: Guido Schmiemann, MD | |
| Medical Practice Schulz | Recruiting |
| Waake, Germany, 37136 | |
| Contact: Wolfgang Schulz +49-5507-7148 annweiler.schweiger@web.de | |
| Principal Investigator: Wolfgang Schulz | |
| Sub-Investigator: Uta Annweiler, MD | |
| Medical Practice Neidhardt | Not yet recruiting |
| Wiefelstede-Metjendorf, Germany, 26215 | |
| Contact: Holger Neidhardt +49-441-77038-0 HolNei@yahoo.de | |
| Principal Investigator: Holger Neidhardt | |
| Medical Practice Stegemann | Recruiting |
| Wunstorf/Luthe, Germany, 31515 | |
| Contact: Rolf Stegemann, MD +49-5031-909030 rolf.stegemann@dga.de | |
| Principal Investigator: Rolf Stegemann, MD | |
Sponsors and Collaborators
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
University Medical Center Goettingen
Investigators
| Principal Investigator: | Eva Hummers-Pradier, Prof. | Abt. Allgemeinmedizin, Universitätsmedizin Göttingen, Humboldtallee 38, 37073 Göttingen |
More Information
No publications provided by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH |
| ClinicalTrials.gov Identifier: | NCT01488955 History of Changes |
| Other Study ID Numbers: | 20110512-BG |
| Study First Received: | December 7, 2011 |
| Last Updated: | April 24, 2013 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH:
|
bacterial infection |
Additional relevant MeSH terms:
|
Urinary Tract Infections Infection Urologic Diseases Anti-Bacterial Agents Fosfomycin Ibuprofen Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic |
Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Central Nervous System Agents |
ClinicalTrials.gov processed this record on May 22, 2013